Sonapax en es it fr

Sonapax Brand names, Sonapax Analogs

Sonapax Brand Names Mixture

  • No information avaliable

Sonapax Chemical_Formula


Sonapax RX_link

Sonapax fda sheet

Sonapax msds (material safety sheet)

Sonapax MSDS

Sonapax Synthesis Reference

Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)

Sonapax Molecular Weight

370.577 g/mol

Sonapax Melting Point

73 oC

Sonapax H2O Solubility

0.0336 mg/L

Sonapax State


Sonapax LogP


Sonapax Dosage Forms

Suspension; Tablet

Sonapax Indication

For the treatment of schizophrenia and generalized anxiety disorder.

Sonapax Pharmacology

Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Sonapax Absorption


Sonapax side effects and Toxicity

LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock

Sonapax Patient Information

Sonapax Organisms Affected

Humans and other mammals